
Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

